Oncology & Cancer

Benefits of prostate-specific antigen testing remain unclear

(HealthDay) -- It remains unclear whether the benefits of prostate-specific antigen (PSA) testing outweigh the harms, but evidence suggests that men with a longer life expectancy may benefit from testing, according to a provisional ...

Oncology & Cancer

Hepatitis B screening before chemo deemed cost-effective

(HealthDay) -- Universal hepatitis B virus (HBV) screening before chemotherapy for lymphoma reduces costs in most settings, according to a study published online June 18 in the Journal of Clinical Oncology.

Genetics

Chromosomal screening improves IVF pregnancy rates

(HealthDay) -- Screening embryos produced by in vitro fertilization using array comparative genomic hybridization (aCGH) plus morphology improves pregnancy rates over screening by morphology alone in single embryo transfers, ...

Oncology & Cancer

Lung cancer screening might pay off, analysis shows

(HealthDay) -- Screening people at high risk for lung cancer could be at least as cost-effective as screening for breast, colorectal and cervical cancers, a new study suggests.

Oncology & Cancer

How cost effective are US cancer prevention services?

Prevention is better than cure; however, when it comes to screening for cancer new research shows that U.S. health services are not as cost-effective as international, and publically run, counterparts. The research, published ...

Oncology & Cancer

ACP releases new colorectal cancer screening guidance statement

The American College of Physicians (ACP) today issued a new guidance statement for colorectal cancer screening. Colorectal cancer is the second leading cause of cancer-related deaths for men and women in the United States. ...

page 14 from 17